Attività
Vendite per attività
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genomic Allergen Rapid Detection
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39% |
Vendite per regione
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 01/11/16 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/01/14 |
Director/Board Member | 59 | 15/10/14 | |
Public Communications Contact | 56 | 01/01/18 | |
Helen Olsson
HRO | Human Resources Officer | 59 | 01/01/20 |
Corporate Officer/Principal | 51 | 01/01/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Founder | 76 | 18/08/10 | |
Director/Board Member | 59 | 15/10/14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 01/01/20 |
Director/Board Member | 65 | 01/01/20 | |
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Ian Kimber
BRD | Director/Board Member | 74 | 01/01/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 24 188 325 | 14 889 392 ( 61,56 %) | 0 | 61,56 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-27,66% | 9,88 Mrd | |
+26,94% | 2,89 Mrd | |
-15,73% | 2,12 Mrd | |
-20,83% | 1,67 Mrd | |
+67,18% | 1,45 Mrd | |
+26,08% | 788 Mln | |
-4,15% | 741 Mln | |
-28,78% | 514 Mln | |
+3,98% | 308 Mln |